BioWorld

May 17, 2004

View Archived Issues

Stock Winners and Losers For The Week

Read More

Clinical Trials Update: April 2004

Read More

Long-Debated EGFR Rash Issue Joined By Mutation Discoveries

Say "Erbitux" to biotechnology investors and you're likely to get a reaction that is definitely...ambivalent. (BioWorld Financial Watch) Read More

Money Raised Year To Date

Read More

Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: April 2004

Read More

FDA Submissions, Approvals And Other Actions: April 2004

Read More

BioWorld Stock Report For Public Biotechnology Companies

Read More